- Joined
- Oct 24, 2010
- Messages
- 3,525
- Reaction score
- 6,393
I don’t know all the details of how the drug is produced but from my experience, there is a significantly huge profit for the CEO’s to take in some nice pay:Quoting a mark up based on the cost of production of a small molecule pill is disingenuous. Pills of almost any type cost near nothing to produce. The cost is in the R&D, trials, approval, and marketing.
$700 for a covid antiviral seems a bit steep, but is probably a hell of a bargain compared to the monoclonal antibodies, and is probably cost effective if it reduces hospitalization by as much as it claims. All the usual caveats of list price != actual price usually apply, as well, the real price for insurers is probably 200-300$
Personally, I'd rather they charge $100 for the covid pill, and up the cost of Ivermectin to $1000/pill. Call it a stupid tax and ride the profit wave (which would be shared by GoFundMe)
Former Executive Chairman Kenneth C. Frazier salary at Merck & Co., Inc. | Salary.com
Salary, bonuses, stock options and other compensation for Kenneth C. Frazier, Former Executive Chairman at Merck & Co., Inc.. How much did Kenneth C. Frazier make in 2022
www1.salary.com
22 million in one year isn’t bad, but nothing compared to the CEO of Regeneron, another GOP favorite (122 million):
REGENERON PHARMACEUTICALS, INC. Executive Salaries & Other Compensation | Salary.com
Salary, bonuses, stock options, stock awards and other compensation information for top executives at REGENERON PHARMACEUTICALS, INC..
www1.salary.com
But yeah, it’s ok to up the cost of drugs because we obviously can’t cut the executives pay.
Last edited: